AzTrials
AzTrials

StrokeNCT05411003

Urdu Version Of Nottingham Extended Activities Of Daily Living Scale: Reliability And Validity Study

An observational study of Stroke, run by Riphah International University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to know the validity and reliability as well as to translate and culturally adapt the Nottingham Extended Activities Of Daily Living Scale into Urdu language in Pakistani population of Stroke. Read more about this study

Who is it for?
Ages 67 years and older
Conditions the study is for
Stroke
How many people
80 participants
Where
1 sitePakistan
Study dates
30 May 2021to 12 Jul 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 67 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Stroke population of Pakistan over 67 years of age

Who may be able to join

  • Having age of 67 years or more
  • Having stroke
  • Both males and females

Who cannot join

  • Neurological condition other than stroke
  • Any fracture of lower extremity
  • Any amputation of lower extremity

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Ripah International University

    Faisalabad, Punjab Province, 38000

Other trials in Pakistan

About this study

Official title: Is Nottingham Extended Activities Of Daily Living Scale in Urdu Language a Reliable and Valid Tool to Assess the Level of Independence While Performing Activities of Daily Livings

The aim of the study is to know the validity and reliability as well as to translate and culturally adapt the Nottingham Extended Activities Of Daily Living Scale into Urdu language in Pakistani population of Stroke. This study also aims to correlate the scale with the Modified Barthel Index and Frenchay Activities Index.

Read the detailed description

As per previous recommendation the English version of Nottingham Extended Activities Of Daily Living Scale will be translated into Urdu and it will be culturally adapted. Nottingham Extended Activities Of Daily Living Scale will be given to eighty individuals of stroke population which were selected on the basis of convenience sampling and the criteria of inclusion and exclusion. Study will investigate both inter-observer and intra-observer reliability of Nottingham Extended Activities Of Daily Living Scale, Modified Barthel Index and Frenchay Activities Index; the 2 set of questionnaire designed will be given to the participants on the same day to be filled, by two observers. And with a gap of half an hour between distributions of first two forms questionnaires will be given for inter-observer assessment. And after a time period of one week a third assessment will be collected by the first observer (intra-observer assessment). Statistical Package of Social Sciences Version 24 will be used for data entry and analysis. Cronbach alpha value will be used for checking internal consistency and intra-class correlation coefficient will be used to analyze test retest reliability.

Conditions
Stroke
Keywords
Nottingham Extended Activities Of Daily Living Scale, Urdu Version, Reliability, Validity, Stroke, Neurological Disorders, Activities of Daily Living
Medical subject headings
Stroke, Nervous System Diseases

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nottingham Extended Activities Of Daily Living Scale

    The purpose of development of Nottingham Extended Activities Of Daily Living Scale was to use it for stroke patients. Each question on the scale is graded either 0 which means patient cannot perform task, 1 which means that patient can do activity but with assistance, 2 which states that task can be performed but with difficulty, 3 which means that he or she can perform the activity on his or her own easily. The score ranges from 0-66.

    Measured: 1st day

  2. Frenchay Activities Index

    The Frenchay Activities Index is a tool for assessing instrumental activities of daily living in stroke patients. It is based upon the frequency in which activities are performed. Frenchay Activities Index scores vary from 0 (inactive) to 45 (very active), with 0-15 indicating inactivity, 16-30 indicating moderate activity, and 31-45 indicating extreme activity. A score of 18 or more than 18 was used to predict minor impairment following a stroke.

    Measured: 1st day

  3. Modified Barthel Index

    The Barthel modified index scale is used to assess behavior related to daily tasks in stroke patients or those with other debilitating conditions. Each activity is given a score ranging from 0 (unable to complete task) to 5, 10, or 15 (highest) (fully independent- exact score depends on the activity being evaluated). Summing the scores for each of the items yields a total score.

    Measured: 1st day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2022
  2. Study start30 May 2021
  3. Primary completion10 Jul 2023
  4. Study completion12 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Prospective
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05411003
Sponsor's protocol ID
REC-FSD-00270
Status last verified
May 2024
First submitted
6 Jun 2022
Last updated
7 May 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nottingham Extended Activities Of Daily Living Scale (time frame: 1st day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in